No abstract available
MeSH terms
-
Antineoplastic Agents / economics
-
Drug Costs*
-
Drug Discovery
-
Drug Industry
-
Episode of Care
-
Fees and Charges*
-
Guideline Adherence
-
Humans
-
Lobbying
-
Medical Oncology / economics*
-
Medicare / economics
-
Physicians / economics
-
Reimbursement Mechanisms / economics*
-
United States